Wire
Barrington Raises Price Target on Lifecore Biomedical to $6 From $5.50, Keeps Outperform Rating
Lifecore Biomedical (LFCR) has an average rating of overweight and mean price target of $6.67 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $5.13, Change: $+0.01, Percent Change: +0.20%
$LFCR
